Gene · 2101
Papers2,737
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 2,737
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A review of alcohol-pathogen interactions: New insights into combined disease pathomechanisms. | Alcohol Clin Exp Res | 2022 | 35076108 | PubTator, text mining | PubMed |
| Role of Metabolic Reprogramming of Long non-coding RNA in Clear Cell Renal Cell Carcinoma. | J Cancer | 2022 | 35069912 | PubTator, text mining | PubMed |
| Roles of ERRα and TGF-β signaling in stemness enhancement induced by 1 µM bisphenol A exposure via human neural stem cells. | Exp Ther Med | 2022 | 35069845 | PubTator, text mining | PubMed |
| Can SARS-CoV-2 Infection Exacerbate Alzheimer's Disease? An Overview of Shared Risk Factors and Pathogenetic Mechanisms. | J Pers Med | 2022 | 35055344 | PubTator, text mining | PubMed |
| The Epithelial-Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression. | Int J Mol Sci | 2022 | 35054987 | PubTator, text mining | PubMed |
| Treatment Strategies Against Triple-Negative Breast Cancer: An Updated Review. | Breast Cancer (Dove Med Press) | 2022 | 35046722 | PubTator, text mining | PubMed |
| Expression and regulation of estrogen receptor 2 and its coregulators in mouse granulosa cells. | J Reprod Dev | 2022 | 35046244 | PubTator, text mining | PubMed |
| Lipid reprogramming induced by the TFEB-ERRα axis enhanced membrane fluidity to promote EC progression. | J Exp Clin Cancer Res | 2022 | 35045880 | PubTator, text mining | PubMed |
| Discovery of New Estrogen-Related Receptor α Agonists via a Combination Strategy Based on Shape Screening and Ensemble Docking. | J Chem Inf Model | 2022 | 35041411 | PubTator, text mining | PubMed |
| The mTOR/PGC-1α/SIRT3 Pathway Drives Reductive Glutamine Metabolism to Reduce Oxidative Stress Caused by ISKNV in CPB Cells. | Microbiol Spectr | 2022 | 35019690 | PubTator, text mining | PubMed |
| Adipocytokines and disease progression in endometrial cancer: a systematic review. | Cancer Metastasis Rev | 2022 | 34951691 | PubTator, text mining | PubMed |
| The discovery of a novel series of potential ERRα inverse agonists based on p-nitrobenzenesulfonamide template for triple-negative breast cancer in vivo. | J Enzyme Inhib Med Chem | 2022 | 34894977 | PubTator, text mining | PubMed |
| How Many Cell Types Are in the Kidney and What Do They Do? | Annu Rev Physiol | 2022 | 34843404 | PubTator, text mining | PubMed |
| Moving Towards Induced Pluripotent Stem Cell-based Therapies with Artificial Intelligence and Machine Learning. | Stem Cell Rev Rep | 2022 | 34843066 | PubTator, text mining | PubMed |
| ERRα expression in ovarian cancer and promotes ovarian cancer cells migration in vitro. | Arch Gynecol Obstet | 2022 | 34797420 | PubTator, text mining | PubMed |
| PGC1α Regulates the Endothelial Response to Fluid Shear Stress via Telomerase Reverse Transcriptase Control of Heme Oxygenase-1. | Arterioscler Thromb Vasc Biol | 2022 | 34789002 | PubTator, text mining | PubMed |
| All roads lead to Rome - a review of the potential mechanisms by which exerkines exhibit neuroprotective effects in Alzheimer's disease. | Neural Regen Res | 2022 | 34782555 | PubTator, text mining | PubMed |
| EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified Neuroblastoma. | Cancer Discov | 2022 | 34772733 | PubTator, text mining | PubMed |
| Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration. | Curr Neuropharmacol | 2022 | 34751120 | PubTator, text mining | PubMed |
| Whole exome sequencing reveals potentially pathogenic variants in a small subset of premenopausal women with idiopathic osteoporosis. | Bone | 2022 | 34743040 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2101/papers?page=38